BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 8957015)

  • 21. Calcium channel subtypes controlling serotonin release from human small cell lung carcinoma cell lines.
    Codignola A; Tarroni P; Clementi F; Pollo A; Lovallo M; Carbone E; Sher E
    J Biol Chem; 1993 Dec; 268(35):26240-7. PubMed ID: 8253745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. omega-Conotoxin-GVIA-sensitive calcium channels on preganglionic nerve terminals in mouse pelvic and celiac ganglia.
    Jobling P
    Auton Neurosci; 2009 Mar; 146(1-2):56-61. PubMed ID: 19162562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lambert-Eaton syndrome antibodies inhibit acetylcholine release and P/Q-type Ca2+ channels in electric ray nerve endings.
    Satoh Y; Hirashima N; Tokumaru H; Takahashi MP; Kang J; Viglione MP; Kim YI; Kirino Y
    J Physiol; 1998 Apr; 508 ( Pt 2)(Pt 2):427-38. PubMed ID: 9508807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biophysical and pharmacological diversity of high-voltage-activated calcium currents in layer II neurones of guinea-pig piriform cortex.
    Magistretti J; Brevi S; de Curtis M
    J Physiol; 1999 Aug; 518 ( Pt 3)(Pt 3):705-20. PubMed ID: 10420008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional characterization of ion permeation pathway in the N-type Ca2+ channel.
    Wakamori M; Strobeck M; Niidome T; Teramoto T; Imoto K; Mori Y
    J Neurophysiol; 1998 Feb; 79(2):622-34. PubMed ID: 9463426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phoneutria nigriventer omega-Phonetoxin IIA: a new tool for anti-calcium channel autoantibody assays in Lambert-Eaton myasthenic syndrome.
    Martin-Moutot N; Haro Ld; Santos RG; Mori Y; Seagar M
    Neurobiol Dis; 2006 Apr; 22(1):57-63. PubMed ID: 16289869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium channel subtypes responsible for voltage-gated intracellular calcium elevations in embryonic rat motoneurons.
    Scamps F; Valentin S; Dayanithi G; Valmier J
    Neuroscience; 1998 Dec; 87(3):719-30. PubMed ID: 9758236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dosage and specificity of anti-calcium channel antibodies in Lambert-Eaton myasthenic syndrome].
    Martin-Moutot N; de Haro L; Seagar M
    Rev Neurol (Paris); 2004 May; 160(5 Pt 2):S28-34. PubMed ID: 15269657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specificity of autoantibodies react with omega-conotoxin MVIIC-sensitive calcium channel in Lambert-Eaton myasthenic syndrome.
    Suenaga A; Shirabe S; Nakamura T; Motomura M; Tsujihata M; Matsuo H; Kataoka Y; Niwa M; Itoh M; Nagataki S
    Muscle Nerve; 1996 Sep; 19(9):1166-8. PubMed ID: 8761275
    [No Abstract]   [Full Text] [Related]  

  • 30. Three high threshold calcium channel subtypes in rat corticotropes.
    Kuryshev YA; Childs GV; Ritchie AK
    Endocrinology; 1995 Sep; 136(9):3916-24. PubMed ID: 7649100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three types of Ca2+ channel trigger secretion with different efficacies in chromaffin cells.
    Artalejo CR; Adams ME; Fox AP
    Nature; 1994 Jan; 367(6458):72-6. PubMed ID: 8107778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuronal calcium channels as target for Lambert-Eaton myasthenic syndrome autoantibodies.
    Sher E; Carbone E; Clementi F
    Ann N Y Acad Sci; 1993 Jun; 681():373-81. PubMed ID: 8395151
    [No Abstract]   [Full Text] [Related]  

  • 33. [Lambert-Eaton syndrome without calcium channel autoantibodies].
    Delpont E; Martin-Moutot N; Brunetto JL; Desnuelle C
    Rev Neurol (Paris); 1994; 150(3):244-7. PubMed ID: 7863174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium channel blockers and transmitter release at the normal human neuromuscular junction.
    Protti DA; Reisin R; Mackinley TA; Uchitel OD
    Neurology; 1996 May; 46(5):1391-6. PubMed ID: 8628488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
    Motomura M; Lang B; Johnston I; Palace J; Vincent A; Newsom-Davis J
    J Neurol Sci; 1997 Mar; 147(1):35-42. PubMed ID: 9094058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. mu-Opioid receptor activation reduces multiple components of high-threshold calcium current in rat sensory neurons.
    Rusin KI; Moises HC
    J Neurosci; 1995 Jun; 15(6):4315-27. PubMed ID: 7540671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-channel properties of four calcium channel types in rat motoneurons.
    Umemiya M; Berger AJ
    J Neurosci; 1995 Mar; 15(3 Pt 2):2218-24. PubMed ID: 7534346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of Ca2+ channel currents in cultured rat cerebellar granule neurones.
    Pearson HA; Sutton KG; Scott RH; Dolphin AC
    J Physiol; 1995 Feb; 482 ( Pt 3)(Pt 3):493-509. PubMed ID: 7738844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological dissection of multiple types of Ca2+ channel currents in rat cerebellar granule neurons.
    Randall A; Tsien RW
    J Neurosci; 1995 Apr; 15(4):2995-3012. PubMed ID: 7722641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [2 components of the high-threshold calcium current possessing different sensitivities to omega-conotoxin in the membrane of pheochromocytoma cells].
    Pogorelaia NKh; Savchenko AN; VerkhratskiÄ­ AN; Shuba IaM
    Neirofiziologiia; 1990; 22(3):397-400. PubMed ID: 2169035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.